These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31438566)
61. Inhibition of the spontaneous polymorphic transition of pyrazinamide γ form at room temperature by co-spray drying with 1,3-dimethylurea. Baaklini G; Dupray V; Coquerel G Int J Pharm; 2015 Feb; 479(1):163-70. PubMed ID: 25556055 [TBL] [Abstract][Full Text] [Related]
62. Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development. Mahlin D; Ponnambalam S; Höckerfelt MH; Bergström CA Mol Pharm; 2011 Apr; 8(2):498-506. PubMed ID: 21344945 [TBL] [Abstract][Full Text] [Related]
63. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. Forster A; Hempenstall J; Rades T J Pharm Pharmacol; 2001 Mar; 53(3):303-15. PubMed ID: 11291745 [TBL] [Abstract][Full Text] [Related]
64. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity? Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914 [TBL] [Abstract][Full Text] [Related]
65. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Forster A; Hempenstall J; Tucker ; Rades T Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862 [TBL] [Abstract][Full Text] [Related]
66. Rheology and molecular mobility of amorphous blends of citric acid and paracetamol. Hoppu P; Hietala S; Schantz S; Juppo AM Eur J Pharm Biopharm; 2009 Jan; 71(1):55-63. PubMed ID: 18656536 [TBL] [Abstract][Full Text] [Related]
67. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods. Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910 [TBL] [Abstract][Full Text] [Related]
68. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers. Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830 [TBL] [Abstract][Full Text] [Related]
69. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride. Karimi K; Katona G; Csóka I; Ambrus R J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047 [TBL] [Abstract][Full Text] [Related]
70. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Dontireddy R; Crean AM Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280 [TBL] [Abstract][Full Text] [Related]
71. Effect of counterions on the properties of amorphous atorvastatin salts. Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794 [TBL] [Abstract][Full Text] [Related]
72. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
73. A comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallization. Tian B; Zhang L; Pan Z; Gou J; Zhang Y; Tang X Int J Pharm; 2014 Nov; 475(1-2):385-92. PubMed ID: 25218489 [TBL] [Abstract][Full Text] [Related]
74. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions. Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218 [TBL] [Abstract][Full Text] [Related]
75. Effect of moisture sorption on tabletting characteristics of spray dried (15% amorphous) lactose. Sebhatu T; Elamin AA; Ahlneck C Pharm Res; 1994 Sep; 11(9):1233-8. PubMed ID: 7816749 [TBL] [Abstract][Full Text] [Related]
76. Second harmonic generation microscopy as a tool for the early detection of crystallization in spray dried dispersions. Correa-Soto C; Trasi NS; Schmitt PD; Su Y; Liu Z; Miller E; Variankaval N; Marsac PJ; Simpson GJ; Taylor LS J Pharm Biomed Anal; 2017 Nov; 146():86-95. PubMed ID: 28866472 [TBL] [Abstract][Full Text] [Related]
77. A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs. Ueda H; Muranushi N; Sakuma S; Ida Y; Endoh T; Kadota K; Tozuka Y Pharm Res; 2016 Apr; 33(4):1018-29. PubMed ID: 26700604 [TBL] [Abstract][Full Text] [Related]
78. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery. Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948 [TBL] [Abstract][Full Text] [Related]
79. Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying. Craye G; Löbmann K; Grohganz H; Rades T; Laitinen R Molecules; 2015 Dec; 20(12):21532-48. PubMed ID: 26633346 [TBL] [Abstract][Full Text] [Related]
80. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions. Ghebremeskel AN; Vemavarapu C; Lodaya M Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]